Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+3.6%
5Y CAGR+19.2%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+3.6%/yr
vs +30.2%/yr prior
5Y CAGR
+19.2%/yr
Recent deceleration
Acceleration
-26.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$383.53M+18.7%
2024$323.06M+0.1%
2023$322.60M-6.4%
2022$344.52M+13.2%
2021$304.36M+91.2%
2020$159.15M+46.0%
2019$108.99M-9.2%
2018$120.03M+166.7%
2017$45.00M+34.2%
2016$33.53M-